BioTherapeutics | 1800 Kraft Dr., Suite 200, Blacksburg, VA, 24060

Publications

Exploratory studies with BT-11: A proposed orally active therapeutic for Crohn’s disease.

Bissel, P., K. Boes, J. Hinckley, B.S. Jortner, G. Magnin-Bissel, S.R. Were, M. Ehrich, A. Carbo, C.W. Philipson, R. Hontecillas, N. Philipson, R.D. Gandour, and J. Bassaganya-Riera
International Journal of Toxicology 2016 Apr 1

Back to top